Connable Office Inc’s GSK GSK Stock Holding History

Connable Office Inc’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-5,272	Closed	-$303K	–	209
2014 Q3	$303K	Hold	5,272	–	–	0.08%	123
2014 Q2	$352K	Sell	5,272 -143	-3%	-$9.68K	0.09%	118
2014 Q1	$362K	Hold	5,415	–	–	0.1%	122
2013 Q4	$361K	Sell	5,415 -172	-3%	-$11.2K	0.1%	123
2013 Q3	$350K	Hold	5,587	–	–	0.1%	150
2013 Q2	$349K	Buy	+5,587	New	+$355K	0.1%	135

Other funds holding GSK

LTI

Laffer Tengler Investments Nashville, Tennessee $677M AUM 27.58% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Connable Office Inc's GSK Position: Q4 2014 in Review

Connable Office Inc sold out of GSK (GSK) in Q4 2014, closing a stake of 5,272 shares — an estimated $303K sold.

Connable Office Inc first reported a position in GSK in Q2 2013 and held it in 6 quarters. The position peaked at $362K in Q1 2014. 728 funds tracked by Wall St. Rank hold GSK as of Q4 2014.

Connable Office Inc reported no remaining GSK position as of Q4 2014 after selling out during the quarter.
Connable Office Inc sold 5,272 GSK shares in Q4 2014, an estimated $303K.
Connable Office Inc first reported a position in GSK in Q2 2013 and held it in 6 quarters.
Connable Office Inc's GSK position peaked at $362K in Q1 2014.
728 funds tracked by Wall St. Rank held GSK as of Q4 2014.

Based on Connable Office Inc's 13F filing for Q4 2014, filed 10 Feb 2015.